We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Antimicrobial Silver Fights Wound Infection

By HospiMedica staff writers
Posted on 02 Jul 2002
A new dressing for wounds features controlled-release antimicrobial silver, designed to fight antibiotic-resistant bacteria, especially in deep, hard-to-treat wounds.

Called Arglaes, the new dressing has no known resistance or major side effects and maintains an effective antimicrobial barrier for up to five days. More...
Utilizing controlled-release polymers, Arglaes delivers a constant stream of silver ions into the wound either in a film or powder form. In addition, the powder form contains alginate to aid in fluid handling. As the powder mixes with wound fluid, it turns into a gel that adheres to the wound bed and is easily removed during wound irrigation. Arglaes is appropriate for use on trauma injuries, incisions, minor burns, dermal lesions, and arterial, venous, and diabetic ulcers. The dressing was developed by Maersk Medical, Inc. (Lynge, Denmark).

"Arglaes appears to have a significant advantage in reducing the incidence of infection,” said Stephen B. Colvin, M.D., chief of cardiothoracic surgery at New York University School of Medicine (NY, USA). Dr. Colvin had conducted clinical and scientific studies using Arglaes and is now using it as part of his post-surgical protocol.




Related Links:
Maersk Medical, Inc.

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
Gas Consumption Analyzer
Anesthetic Gas Consumption Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.